about
Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patientsUnusual cytogenetic findings in a synovial sarcoma arising in the paranasal sinuses.Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinomaKRAS mutation in lung metastases from colorectal cancer: prognostic implications.Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.Van-Gogh-like 2 antagonises the canonical WNT pathway and is methylated in colorectal cancersPrognostic value of colorectal cancer biomarkers.Early expression of the fractalkine receptor CX3CR1 in pancreatic carcinogenesisMolecular heterogeneity and prognostic implications of synchronous advanced colorectal neoplasiaPresence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers.The chemokine receptor CX3CR1 is involved in the neural tropism and malignant behavior of pancreatic ductal adenocarcinoma.Expression of chemokines and chemokine receptors in human colon cancer.Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer.The Fractalkine-Receptor Axis Improves Human Colorectal Cancer Prognosis by Limiting Tumor Metastatic Dissemination.Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers.Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer.Evolving notions on immune response in colorectal cancer and their implications for biomarker development.Molecular analysis of the Pendred's syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred's syndrome.Hereditary or sporadic polyposis syndromes.Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression.Mutant cohesin drives chromosomal instability in early colorectal adenomas.Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study.Carriage of CARD15 variants and smoking as risk factors for resective surgery in patients with Crohn's ileal disease.CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal studySPINK1 and PRSS1 mutations in benign pancreatic hyperenzymemiaEGFR overexpression in malignant pleural mesotheliomaBone mineral density and body composition in ulcerative colitis: a six-year follow-upCommon occurrence of multiple K-RAS mutations in pancreatic cancers with associated precursor lesions and in biliary cancersMethylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinomaReduced likelihood of metastases in patients with microsatellite-unstable colorectal cancerRe: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instabilityGene methylation in pleural mesothelioma: correlations with clinico-pathological features and patient's follow-upHow dense, how intense? Role of tumour-infiltrating lymphocytes across colorectal cancer stages. Re: Nosho et al. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol
P50
Q28346761-E76FEA9E-83D1-4265-BDF6-9C6DB2DC8D98Q33208709-C221888D-F676-4F7A-B15E-18290D911DE1Q34430572-B1092F57-2F6F-4EC1-8A00-EC53B3C67035Q36528345-14DC0248-0A1A-459A-93B7-75E9297EE6D8Q36612446-CE6A0ADC-8E57-4F60-B8FC-D0639BA9E771Q36889627-8646F10E-C725-4094-83F9-11FD3384CF02Q37132721-94B6C980-54D3-448D-A273-E45534736D7EQ37279237-6D1AA73E-9190-4734-AC1C-1439909A463BQ37632108-EC3CF22A-198D-4954-BD48-2D58A8B2FA9FQ39150451-AD51F921-1292-42EF-8DA2-E1B443E84A33Q39365686-6D2BE7A6-D749-41C6-9A75-47AD915404F9Q39923060-85C8B906-2B7F-47D9-B3CB-2D0AF3AC4532Q39979306-C3A56511-91FF-4861-8668-6191E594DADBQ40873602-19BFCE61-E0C8-42DC-A8B2-D2F504B049CCQ41046026-B923D6A7-00C0-43B5-A5BB-344271A683F4Q45118047-E0F03010-8CB1-4778-808C-621D940BC43AQ47131106-487C5F8A-B356-44A5-BADE-2563ABF06A2BQ50098505-CAA197C8-81E5-4615-863F-FE39D1053FF5Q50495434-ACED448F-0C35-4FFB-9419-A6B15BCC3DCEQ51800903-BE336215-A908-4547-8630-341D347E7A0EQ52626849-BA0A8E3C-DB43-4AE5-8B2B-131C53C1845FQ53030454-933E04B6-A529-4945-89DD-B9E6BCD88624Q53913562-65AF1E0B-6B53-4667-8672-AAD2EC502C53Q54642773-5651E7CF-68A3-45CC-A6EB-E3B2D4D485E1Q56942543-C78B766A-F8A3-43E0-9F88-E5258990FB89Q56992794-1505B1D7-375B-4C39-801F-B956E5829C51Q61698043-57E434A3-B16B-4816-BD3A-5E4203D3BDB0Q74159080-453A8591-67CE-4A8F-ACC2-04108F65B413Q74355548-27773456-1277-4D81-84A9-FF3F9FE3EB52Q74525168-A3EFDA8A-963F-4AE2-8C33-CAD67F47EFA6Q80557773-99DDF235-23F5-465B-BAFF-9CFA0545B2E8Q80563869-A26B4F2A-3814-4EC0-82DF-3621B5B6F437Q81405822-CE525387-A095-41D0-A826-2E9B84719DB4Q84725715-289E0005-AFF3-4492-9832-F4FF568F113F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Paolo Bianchi
@ast
Paolo Bianchi
@en
Paolo Bianchi
@es
Paolo Bianchi
@nl
type
label
Paolo Bianchi
@ast
Paolo Bianchi
@en
Paolo Bianchi
@es
Paolo Bianchi
@nl
prefLabel
Paolo Bianchi
@ast
Paolo Bianchi
@en
Paolo Bianchi
@es
Paolo Bianchi
@nl
P106
P1153
55702521461
P31
P496
0000-0001-5786-5644